Increased adrenomedullin protein content and mRNA expression in human fetal membranes but not placental tissue in pre-eclampsia

• Published in: Molecular human reproduction Vol. 12; no. 3; pp. 181 - 186
• Main Authors: Al-Ghafra, A., Gude, N.M., Brennecke, S.P., King, R.G.
• Format: Journal Article
• Language: English
• Published: Oxford Oxford University Press 01.03.2006; Oxford Publishing Limited (England)
• Subjects: Adrenomedullin; Amnion - metabolism; Biological and medical sciences; Blotting, Northern; Chorion - metabolism; Embryology: invertebrates and vertebrates. Teratology; Extraembryonic Membranes - metabolism; Female; fetal membranes; Fundamental and applied biological sciences. Psychology; Humans; Peptides - genetics; Peptides - metabolism; placenta; Placenta - metabolism; pre-eclampsia; Pre-Eclampsia - genetics; Pre-Eclampsia - metabolism; Pregnancy; RNA, Messenger - genetics; RNA, Messenger - metabolism; Human; Tissue; Placenta; Pregnancy disorders; Fetal membrane; Preeclampsia; Adrenomedullin; Gene expression; Fetoplacental membrane; adrenomedullin/fetal membranes/placenta/pre-eclampsia; Pregnancy toxemia; Protein content
• ISSN: 1360-9947; 1460-2407
• DOI: 10.1093/molehr/gal016

The relationship between Pre-eclampsia (PE) and placental production of Adrenomedullin (AdM) is not completely understood. This study measured placental and fetal membrane AdM protein concentrations by specific radioimmunoassay and mRNA expression by Northern blot analysis in samples obtained at either term or preterm gestation from women either in labour or not in labour. Samples were obtained from women with normotensive and pre-eclamptic pregnancies. There were significant increases in immunoreactive AdM protein concentration (pg/mg DNA) in choriodecidua and amnion of women with PE compared to normal pregnancy for the preterm not-in-labour group (choriodecidua: control 124 ± 16, n = 10, PE 361 ± 35, n = 10; amnion: control 94 ± 12, n = 10, PE 153 ± 19, n = 10) and for the term not-in-labour (choriodecidua: control 128 ± 17, n = 14, PE 459 ± 51, n = 8; amnion: control 112 ± 15, n = 14, PE 253 ± 57, n = 8) and in-labour (choriodecidua: control 531 ± 74, n = 14, PE 881 ± 188, n = 8; amnion: control 545 ± 84, n = 14, PE 1008 ± 230, n = 8) groups. AdM mRNA relative abundance was greater in preterm, not-in-labour choriodecidual samples in PE, but not in amnion. In addition, this study observed labour-associated increases in choriodecidual and amniotic irAdM in term pre-eclamptic and control patients. However, there were no significant changes in AdM protein or mRNA expressions between any of the groups for placental tissue. These results suggest that fetal membranes, but not placental, production of AdM is increased at the post-translational level during PE in preterm and term tissues and at the pre-translational level during PE in preterm tissues. Fetal membranes, AdM may play an important role in the regulation of feto-placental hemodynamics and fetal physiology during pre-eclampsia.